Show simple item record

dc.contributor.authorIsrael, K. Njovu
dc.contributor.authorBenson, Musinguzi
dc.contributor.authorJames, Mwesigye
dc.contributor.authorKennedy, Kassaza
dc.contributor.authorJoseph, Turigurwa
dc.contributor.authorEdwin, Nuwagira
dc.contributor.authorJoel, Bazira
dc.contributor.authorTaseera, Kabanda
dc.contributor.authorMoses, Mpeirwe
dc.contributor.authorLucas, Ampaire
dc.contributor.authorAndrew, Mutekanga
dc.contributor.authorJames, Kiguli
dc.contributor.authorBeatrice, Achan
dc.contributor.authorHerbert, Itabangi
dc.date.accessioned2024-06-24T06:04:27Z
dc.date.available2024-06-24T06:04:27Z
dc.date.issued2021
dc.identifier.citationNjovu, I.K., Musinguzi, B., Mwesigye, J., Kassaza, K., Turigurwa, J., Nuwagira, E., Bazira, J., Kabanda, T., Mpeirwe, M., Ampaire, L. and Mutekanga, A., 2021. Status of pulmonary fungal pathogens among individuals with clinical features of pulmonary tuberculosis at Mbarara University Teaching Hospital in Southwestern Uganda. Therapeutic advances in infectious disease, 8, p.20499361211042477.en_US
dc.identifier.issnhttps://journals.sagepub.com/doi/full/10.1177/20499361211042477
dc.identifier.urihttp://hdl.handle.net/10570/13288
dc.description.abstractBackground: Pulmonary mycoses are important diseases of the respiratory tract caused by pulmonary fungal pathogens. These pathogens are responsible for significant morbidity and mortality rates worldwide; however, less attention has been paid to them. In this study we determined the prevalence of pulmonary fungal pathogens among individuals with clinical features of pulmonary tuberculosis at Mbarara Regional Referral Hospital. Method: This was a hospital based cross sectional survey. Sputum samples were collected from each study participant. For each sample, the following tests were performed: Sabouraud dextrose agar for fungal culture, GeneXpert for Mycobacteria tuberculosis (MTB) and potassium hydroxide for fungal screening. Filamentous fungal growth and yeasts were further examined with lactophenol cotton blue staining and germ tube respectively. Results: Out of 113 study participants, 80 (70.7%) had pulmonary fungal pathogens whilst those with pulmonary tuberculosis numbered five (4.4%). Candida albicans [21 (22.58%)] and Aspergillus species [16 (17.20%)] were the pathogens most identified among others. Two (1.7%) TB GeneXpert positive participants had fungal pathogens isolated from their sputum samples. We established a prevalence of 57 (71.3%) for pulmonary fungal pathogen (PFP) isolates, three (60.0%) for MTB in HIV positive patients and 18 (22.5%) for PFP, and zero (0.0%) for MTB in HIV negative patients. On the other hand, two (100%) HIV positive patients had both PFP isolates and MTB. Conclusion: Our findings highlight the diversity of neglected pulmonary fungal pathogens whose known medical importance in causing pulmonary mycoses cannot be over emphasized. Therefore this presents a need for routine diagnosis for pulmonary mycoses among TB suspects and set-up of antimicrobial profile for pulmonary fungal isolates to support clinical management of these cases.en_US
dc.publisherTherapeutic advances in infectious diseaseen_US
dc.relation.ispartofseries;1-11
dc.subjectpulmonary fungal infections, pulmonary fungal pathogens, pulmonary mycoses, pulmonary tuberculosisen_US
dc.titleStatus of pulmonary fungal pathogens among individuals with clinical features of pulmonary tuberculosis at Mbarara University Teaching Hospital in Southwestern Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record